Zobrazeno 1 - 10
of 161
pro vyhledávání: '"Lars, Beckman"'
Publikováno v:
BMC Palliative Care, Vol 23, Iss 1, Pp 1-11 (2024)
Abstract Background Men with metastatic castration-resistant prostate cancer (mCRPC) have an incurable disease. Along with prolonging life, symptom management is one of the main goals with treatment. This is also important from a palliative care pers
Externí odkaz:
https://doaj.org/article/875263421e5d4d4ba4ab7cc6d67687a6
Publikováno v:
BMC Public Health, Vol 23, Iss 1, Pp 1-19 (2023)
Abstract Background The majority of childhood, Adolescent and Young Adult (AYA) cancer survivors suffers from long-lasting health issues following cancer treatment. It is therefore critical to explore effective health promotion strategies to address
Externí odkaz:
https://doaj.org/article/0e2ca828a9bf420c9c04eae750339dab
Autor:
Ulrika Björeland, Kristina Notstam, Per Fransson, Karin Söderkvist, Lars Beckman, Joakim Jonsson, Tufve Nyholm, Anders Widmark, Camilla Thellenberg Karlsson
Publikováno v:
Radiation Oncology, Vol 18, Iss 1, Pp 1-11 (2023)
Abstract Background Perirectal spacers may be beneficial to reduce rectal side effects from radiotherapy (RT). Here, we present the impact of a hyaluronic acid (HA) perirectal spacer on rectal dose as well as spacer stability, long-term gastrointesti
Externí odkaz:
https://doaj.org/article/9485e5dcaba849909458379c30d021a6
Autor:
Ulrika Björeland, Tufve Nyholm, Joakim Jonsson, Mikael Skorpil, Lennart Blomqvist, Sara Strandberg, Katrine Riklund, Lars Beckman, Camilla Thellenberg-Karlsson
Publikováno v:
Physics and Imaging in Radiation Oncology, Vol 17, Iss , Pp 117-123 (2021)
Background and purpose: In locally advanced prostate cancer (PC), androgen deprivation therapy (ADT) in combination with whole prostate radiotherapy (RT) is the standard treatment. ADT affects the prostate as well as the tumour on multiparametric mag
Externí odkaz:
https://doaj.org/article/f77e9aa956b84029bb3ec550862443fe
Autor:
Björn Tavelin, Mihajl Seke, David Norman, Lars Franzén, Anders Widmark, Per Fransson, Lars Beckman, Björn Zackrisson, Morten Høyer, Per Nilsson, Camilla Thellenberg-Karlsson, Elisabeth Kjellén, Jon Kindblom, Adalsteinn Gunnlaugsson, Bengt Johansson, Kirsten Björnlinger, Claes Ginman, Magnus Lagerlund, Måns Agrup
Publikováno v:
Fransson, P, Nilsson, P, Gunnlaugsson, A, Beckman, L, Tavelin, B, Norman, D, Thellenberg-Karlsson, C, Hoyer, M, Lagerlund, M, Kindblom, J, Ginman, C, Johansson, B, Björnlinger, K, Seke, M, Agrup, M, Zackrisson, B, Kjellén, E, Franzén, L & Widmark, A 2021, ' Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC) : patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial ', The Lancet Oncology, vol. 22, no. 2, pp. 235-245 . https://doi.org/10.1016/S1470-2045(20)30581-7
Background: The HYPO-RT-PC trial compared conventionally fractionated radiotherapy with ultra-hypofractionated radiotherapy in patients with localised prostate cancer. Ultra-hypofractionation was non-inferior to conventional fractionation regarding 5
Autor:
Maja Holm, Ulrika Rönningås, Agneta Wennman-Larsen, Per Fransson, Lars Beckman, Sandra Doveson
Publikováno v:
European Journal of Cancer Care. 31
OBJECTIVE: Signs and symptoms are important in monitoring prostate cancer, but there is a lack of understanding about the men's interpretation of signs and symptoms in relation to disease progression in advanced phases of the disease. The aim was to
Publikováno v:
The European journal of health economics : HEPAC : health economics in prevention and care.
Background Economic evidence for comparing low fraction with ultra-hypo fractionated (UHF) radiation therapy in the treatment of intermediate-to-high-risk prostate cancer (PC) is lacking, especially in Europe. This study presents an economic evaluati
Autor:
Lars Edenbrandt, Camilla Thellenberg, Aseem Anand, Jon Kindblom, Jan Henry Svensson, Anders Widmark, Anders Ullén, Anders Bjartell, Elin Trägårdh, Lars Beckman
Publikováno v:
Journal of Nuclear Medicine. 61:671-675
For effective clinical management of patients being treated with 223Ra, there is a need for radiographic response biomarkers to minimize disease progression and to stratify patients for subsequent treatment options. The objective of this study was to
Autor:
Tufve Nyholm, Camilla Thellenberg-Karlsson, Mikael Skorpil, Ulrika Björeland, Katrine Riklund, Joakim Jonsson, Lars Beckman, Lennart Blomqvist, Sara Strandberg
Publikováno v:
Physics and Imaging in Radiation Oncology, Vol 17, Iss, Pp 117-123 (2021)
Physics and Imaging in Radiation Oncology
Physics and Imaging in Radiation Oncology
Background and purpose In locally advanced prostate cancer (PC), androgen deprivation therapy (ADT) in combination with whole prostate radiotherapy (RT) is the standard treatment. ADT affects the prostate as well as the tumour on multiparametric magn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::507b9c25a5a6c1d91adfd173d0d10368
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-181012
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-181012
Autor:
Camilla Thellenberg-Karlsson, Jon Kindblom, Marie eva hjälm-Eriksson, Ingela Franck Lissbrant, Lars Beckman, Karin Soderqvist, Johan Styrke
Publikováno v:
Journal of Clinical Oncology. 40:TPS192-TPS192
TPS192 Background: Radiotherapy of the primary tumor in metastatic prostate cancer is life-prolonging in patients with limited disease spread. Several different fractionation schedules have been used, most widely used is a four-week schedule of 2.75-